Evidence map›Paper›PMID 36266158›Full record

ArticleDrug and alcohol dependence2022

Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: Data from the C3PNO Consortium.

L King, K Hayashi, B Genberg, J Choi, K DeBeck, G Kirk, S H Mehta, M Kipke, R D Moore, M K Baum and 6 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 2 countries.

L KingBritish Columbia Centre for Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z2A9, Canada; University of British Columbia, Faculty of Medicine, 317 - 2194 Health Sciences Mall, Vancouver V6T 1Z3, BC, Canada.
K HayashiBritish Columbia Centre for Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z2A9, Canada.
B GenbergThe John Hopkins Bloomberg School of Public Health, 615N Wolfe St, Baltimore, MD, United States.
J ChoiBritish Columbia Centre for Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z2A9, Canada.
K DeBeckBritish Columbia Centre for Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z2A9, Canada; Simon Fraser University School of Public Policy, 8888 University Dr, Burnaby, BC, Canada, V5A 1S6.
G KirkThe John Hopkins Bloomberg School of Public Health, 615N Wolfe St, Baltimore, MD, United States.
S H MehtaThe John Hopkins University, Department of Epidemiology, 615N Wolfe Dr, Baltimore, MD, United States.
M KipkeUniversity of Southern California Keck School of Medicine, 1975 Zonal Ave, Los Angeles, CA, United States.
R D MooreThe John Hopkins University School of Medicine, 733N Broadway, Baltimore, MD, United States.
M K BaumFlorida International University, Department of Dietetics and Nutrition, 1250 SW 108th Ave, Miami, FL, United States.
S ShoptawUniversity of California Los Angeles, Department of Family Medicine, 100 Medical Plaza Driveway, Los Angeles, CA, United States.
P M GorbachUniversity of California Los Angeles, Department of Epidemiology, 10833 Le Conte Ave, Los Angeles, CA, United States.
B MustanskiNorthwestern University, Department of Medical Social Sciences, 625N Michigan Ave, Chicago, IL, United States.
M JavanbakhtUniversity of California Los Angeles, Department of Epidemiology, 10833 Le Conte Ave, Los Angeles, CA, United States.
S SiminskiFrontier Science Foundation, 4033 Maple Road, Amherst, NY, United States.
M-J MilloyBritish Columbia Centre for Substance Use, 400-1045 Howe Street, Vancouver, BC V6Z2A9, Canada; University of British Columbia, Department of Medicine, 2775 Laurel Street, Vancouver, BC, Canada V5Z 1M9. Electronic address: mj.milloy@bccsu.ubc.ca.
British Columbia Centre on Substance Use · CAJohns Hopkins University · USUniversity of California, Los Angeles · USFlorida International University · USFrontier Science & Technology Research Foundation · USLos Angeles Medical Center · USNorthwestern University · USSimon Fraser University · CAUniversity of Southern California · US

Funding

The AIDS Linked to the Intravenous Experience (ALIVE) StudyU01DA036297 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Gregory D Kirk, Shruti H Mehta · 2014 to 2026
$28.9M
Young Men of Color Who Have Sex with Men Cohort StudyU01DA036926 · NIDA · CHILDREN'S HOSPITAL OF LOS ANGELES · PI GOLDBACH, JEREMY THOMAS, KIPKE, MICHELE D. · 2015 to 2024
$23.3M
Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDSU01DA038886 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI DEBECK, KORA, HAYASHI, KANNA · 2015 to 2024
$12.1M
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable PopulationsU01DA040381 · NIDA · FLORIDA INTERNATIONAL UNIVERSITY · PI BAUM, MARIANNA K · 2015 to 2022
$9.6M
Impacts of universal access to HIV/AIDS care among HIV+ injection drug usersU01DA021525 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MILLOY, M-J · 2017 to 2024
$4.3M
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United StatesR01DA053136 · NIDA · JOHNS HOPKINS UNIVERSITY · PI GENBERG, BECKY LYNN · 2020 to 2024
$3.2M
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase IIU01MD017423 · NIMHD · FLORIDA INTERNATIONAL UNIVERSITY · PI BAUM, MARIANNA K · 2022 to 2023
$2.2M
NIDA NIH HHS R01 DA053136NIDA NIH HHS U01 DA021525NIDA NIH HHS U01 DA036297NIDA NIH HHS U01 DA036926NIDA NIH HHS U01 DA038886NIDA NIH HHS U01 DA040381NIMHD NIH HHS U01 MD017423
6 · The paper itself

Abstract

backgroundData from the COVID-19 pandemic describes increases in drug use and related harms, especially fatal overdose. However, evidence is needed to better understand the pathways from pandemic-related factors to substance use behaviours. Thus, we investigated stockpiling drugs among people who use drugs (PWUD) in five cities in the United States and Canada.

methodsWe used data from two waves of interviews among participants in nine prospective cohorts to estimate the prevalence and correlates of stockpiling drugs in the previous month. Longitudinal correlates were identified using bivariate and multivariate generalized linear mixed-effects modeling analyses.

resultsFrom May 2020 to February 2021, we recruited 1873 individuals who completed 2242 interviews, of whom 217 (11.6%) reported stockpiling drugs in the last month at baseline. In the multivariate model, stockpiling drugs was significantly and positively associated with reporting being greatly impacted by COVID-19 (Adjusted Odds Ratio [AOR]= 1.21, 95% CI: 1.09-1.45), and at least daily use of methamphetamine (AOR = 4.67, 95% CI: 2.75-7.94) in the past month.

conclusionsWe observed that approximately one-in-ten participants reported stocking up on drugs during the COVID-19 pandemic. This behaviour was associated with important drug-related risk factors including high-intensity methamphetamine use. While these correlations need further inquiry, it is possible that addressing the impact of COVID-19 on vulnerable PWUD could help limit drug stockpiling, which may lower rates of high-intensity stimulant use.

Indexed as

COVID-19Drug OverdoseMethamphetamineHumansPandemicsProspective StudiesMethamphetamineCOVID-19OverdoseRisky drug useStockpiling drugsSubstance use

Identifiers

PMID36266158
PMCPMC9535877
OpenAlexW4302362995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.